According to our latest study on “Infectious Disease Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – Product, Technology, Testing Type, Disease Indication, and End User," the market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Infectious Disease Diagnostics Market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also predicts the influence of different industry aspects on the Infectious Disease Diagnostics market segments and regions.

The report highlights the major factors driving the market and prominent players and their developments. The growth of the global infectious disease diagnostic market is majorly driven by an increase in the prevalence of infectious diseases, including hepatitis, influenza, COVID-19, and human immunodeficiency virus (HIV); a rise in demand for point-of-care diagnostic tests; a surge in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, the high cost associated with diagnostic instruments and the lack of skilled technicians in the global market is hampering the market growth.

The COVID-19 pandemic led to increased demand for various point-of-care testing (POCT) diagnostic kits, which provide early detection and help control the spread of COVID-19. SARS-CoV-2 screening diagnostics are constantly being developed to meet the needs of markets with unique regulatory constraints. For example, in February 2022, Mylab Discovery Solutions launched CoviSwift, a point-of-care (POC) RT-PCR testing solution utilized in-hospital labs, small labs, airports, and communities. Moreover, in November 2021, Detect launched a new PCR-quality at-home COVID-19 quick molecular test to address testing needs in the US at work, home, and schools. Similarly, in March 2020, BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes. In March 2022, SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced the completion of the diagnostic research project PoC-BoSens led by the Fraunhofer Institute for Reliability and Microintegration (IZM).

The PoC-BoSens platform is a revolutionary label-free point-of-care device based on three-dimensional photonic bottle resonators (3D-BMRs) for real-time high-sensitive measurement of disease-relevant biomolecules. As a result, the need for infectious disease diagnostic products is rising, with many people suffering from COVID-19. Many diagnostic laboratories and testing facilities are also launched that are expanding the scope of the market. For instance, in June 2020, the Union Minister of Health and Family Welfare launched India’s first mobile I-Lab (Infectious disease diagnostic lab) for COVID-19 testing. Such developments are anticipated to boost the demand for infectious disease diagnostic products in the coming years. Thus, the pandemic has profoundly impacted the public health profession. Therefore, increased production by the companies resulted in profits, and the COVID-19 outbreak has positively impacted the infectious disease diagnostics market growth.

Get PDF Sample Copy At https://www.theinsightpartners.com/sample/TIPHE100001430/

Infectious Disease Diagnostics Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

Table of content:                                                                   

1 Introduction

2 Key Takeaways

3 Infectious Disease Diagnostics Market Landscape

4 Infectious Disease Diagnostics Market – Key Industry Dynamics

5 Infectious Disease Diagnostics Market Analysis- Global

6 Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 – Component

7 Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 -Services Model

8 Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 – Deployment Model

9 Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 – Vertical

10 Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

11 Industry Landscape

12 Competitive Landscape

13 Infectious Disease Diagnostics Market, Key Company Profiles

14 Appendix

About Us:                                                                                                           

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:                                                                                                                  

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com